The mutagenic potential of inhaled anaesthetics has been investigated extensively over the past decade (Baden and Rice, 1986) . The most recently introduced volatile anaesthetics, isoflurane and enflurane, are not mutagenic when examined in various systems using single-and multi-cell organisms. Halo thane, which is still widely used in many countries, is not mutagenic except in a sex-linked recessive assay using the fruit fly, Drosophila melanogaster. Although these anaesthetics, and many others, have been tested alone, they are usually administered clinically with nitrous oxide. To date, no information exists on the mutagenic potential of such combinations. The present study was undertaken to examine the mutagenicity of halothane, isoflurane and enflurane in combination with nitrous oxide.
SUMMARY
combination with 75% nitrous oxide. Control groups of flies were exposed to room air alone. Other groups were exposed at the same time to nitrous oxide, enflurane or isoflurane alone. They served as controls for this and a previous study, the results of which have been reported previously (Kundomal and Baden, 1985) . During exposure, the concentration of oxygen was monitored by an IL 402 oxygen monitor (Instrumentation Laboratory, Lexington, Massachusetts) and maintained at 21 ± 1 %. The balance of gas in the desiccators was nitrogen. Anaesthetic concentrations were measured at the start and end of exposure using gas chromatography or infra-red gas analysis and were always within 5 % of the desired values. The temperature was maintained at 25 ± 1 °C and the relative humidity was maintained at 5O±5%.
Immediately following exposure, 30 male flies from each treatment group were selected at random. Each male was individually mated with three untreated virgin female flies of the Base strain in individual vials with fresh medium (Carolina Biological Supply, Burlington, North Carolina). Three days after mating and after the eggs were deposited (first brood), female flies were discarded and male flies were immediately mated individually with three fresh Base females in new vials to produce the second brood. Three days later, the mating procedure was repeated to produce the third brood. Thus, the mutagenicity of the anaesthetic combinations on germ cells at different stages (spermatozoa, spermatids and spermatocytes) was tested. The Fj (first filial generation) flies were collected for 2-3 days to ensure adequate numbers and sexual maturity. The F, female flies with kidney-shaped red eyes then were mated indi-vidually with three of their Base brothers in individual vials. Twenty or more F t females flies were mated from each of the 30 P, (first parental generation) treated male flies, for a total of about 600 F^P, (first filial-second parental generation) female flies per brood (table I). The Fj-P 2 flies were removed from the vials after 5 days and their eggs allowed to hatch. Cultures were kept for 12-14 days to guarantee that male flies with semilethal mutations characterized by a longer development hatched. The F 2 (second filial generation) progeny for each brood were examined using a dissecting microscope over a 10-day period, beginning with day 1 of emergence of fly from pupa, to determine the occurrence of sex-linked recessive lethals. The absence of wild-type males indicated lethality. Only cultures with 40 or more progeny (males and females together) were included. If 40 or more progeny were present, and no wild-type male flies were observed, the culture was deemed to contain a lethal, since the chance of a type I error is less than 1 in 1000. The frequency of lethals was calculated by dividing the number of lethals found in each brood by the total number of tested Xchromosomes in each brood. The Fisher's exact test was used to compare the lethal mutation rates among the treatment groups. P < 0.05 was considered significant.
RESULTS
The spontaneous rate of sex-linked recessive mutations observed in the control group of male wild-type flies exposed only to air was 0.22% (table I) . This value is within the normal range found by other investigators (Wurgler, Sobels and Vogel, 1977) . Rates of mutation for flies exposed to nitrous oxide, enflurane of isoflurane alone were 0.27%, 0.17% and 0.32%, respectively, and were not significantly different from control values (Kundomal and Baden, 1985) . Neither 2% enflurane nor 2 % isoflurane was mutagenic in the presence of 75 % nitrous oxide (table I) .
Halothane produced a dose-dependent increase in the rate of lethal mutations: 1 % and 2 % concentrations produced about four-fold and seven-fold increases above control, respectively (table I) . A dose-dependent increase above two-fold is generally considered a positive response (Wurgler, Sobels and Vogel, 1977) . There was no difference in mutagenic response among the broods, indicating that all stages of germ cells were equally affected. Nitrous oxide had no effect on the mutagenicity of halothane.
DISCUSSION
Nitrous oxide has no mutagenic activity when tested alone in a variety of assays with bacteria, mammalian cells or whole animals (Baden, 1985) . In particular, it is not mutagenic when tested with Drosophila melanogaster in the sex-linked recessive assay (Kundomal and Baden, 1985) . Nitrous oxide interferes, however, with vitamin B 12 and folate metabolism and can thereby produce several long-term toxic effects in both experimental animals and man (Nunn and Chanarin, 1985) . It also is synergistic with halothane in the production of nuclear abnormalities in dividing fibroblasts (Sturrock and Nunn, 1976) . Finally, it has the potential for enhancing the acute hepatotoxicity of halothane in experimental animals (Ross, Monk and Duffy, 1984) . Thus, one may reasonably hypothesize that, although not itself a chemical mutagen, nitrous oxide enhances the mutagenic potential of other drugs such as halothane, enflurane and isoflurane. Results from the present study do not support such a hypothesis. This is encouraging, since nitrous oxide and volatile anaesthetics are commonly administered together to patients, and are present together in the waste anaesthetic gases which may be inhaled by operating room personnel.
The positive mutagenic response seen in the present study with halothane alone needs to be put in perspective. This finding is consistent with those from previous studies in this species performed by ourselves (Kundomal and Baden, 1985) and others (Kramers and Burm, 1979; Clements and Todd, 1981) . In general, there are several toxicological implications if a chemical is found to be a mutagen (Flamm and Lorentzen, 1985) . First, mutagens produce heritable changes in genetic information which usually are deleterious and may produce a variety of congenital anomalies in future generations. Second, chemicals able to bind covalently to DNA and produce mutations are often able to bind covalently to other tissue macromolecules such as proteins and lipids and produce further toxicity. Third, mutations are thought to be important first steps in the formation of cancers.
Whilst the importance of chemical mutagens is not in doubt, the best method with which to identify them remains uncertain. Since no single test is completely reliable, most authorities believe that a battery of tests should be performed and that a positive response should be seen in several before a chemical is labelled as a mutagen (Flamm and Lorentzen, 1985) . On this basis, halothane cannot be regarded as a proven chemical mutagen because it is not mutagenic other than in the Drosophila assay. In particular, it is not mutagenic when tested under a wide variety of conditions in the Ames test using bacteria to which mammalian enzyme systems have been added (Baden et al., 1976; Waskell, 1978) . It also does not induce sister chromatid exchanges, widely regarded as related to mutations, in cultered Chinese hamster ovary cells at clinical concentrations (White et al., 1979) ; nor does it cause mutations in cultured Chinese hamster lung fibroblast cells using the azaguanine test system (Sturrock, 1977) . Finally, halothane lacks mutagenic effects when administered to rodents in vivo at various clinical doses (Basler and Rohrborn, 1981) . In keeping with its lack of mutagenicity in mammalian test systems is its lack of carcinogenicity (Eger et al., 1978; Baden et al., 1979; Coate, Ulland and Lewis, 1979) and teratogenicity (Kennedy et al., 1976; Landsdown et al., 1976; Wharton et al., 1979) when tested in vivo in various bioassays with rodents. Overall, negative results in mammalian test systems and failure to enhance the mutagenic response with nitrous oxide in Drosophila suggest that mutation and its consequences are unlikely features of halothane toxicity in the clinical setting.
